Skip to content

Magneto-encephalography (MEG) to image the brain*s role in the analgesic effects of Spinal Cord Stimulation (SCS), an explorative study

Magneto-encephalography (MEG) to image the brain*s role in the analgesic effects of Spinal Cord Stimulation (SCS), an explorative study - MEGSCS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46671
Enrollment
25
Registered
2018-03-12
Start date
2018-03-16
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cortical correlates of neuropathic pain workingsmechanisms of spinal cord stimulation

Interventions

In a double-blind randomized design, patients will receive conventional tonic SCS, burst SCS and placebo SCS, each for a one-week period. Four MEG sessions will be performed at baseline and with ton

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: a patient with SCS must meet the following criteria: * Over 18 years, * SCS for at least 3 months, * Stable response to conventional (tonic) stimulation, * Pulse generator suitable for burst stimulation, * Active tip of the implanted electrode at spinal level Th8 or below, * Pulse generator implanted in the lower body, * Capable of participation: travelling to the institute and filling in the questionnaires;a control subject with pain must meet the following criteria: * Over 18 years, * Chronic neuropathic pain in the lower body part, * Preferably on a waiting list for a SCS implant, * Capable of participation: travelling to the institute and filling in the questionnaires.;a control subject without pain must meet the following criteria: * Over 18 years, * No pain or other neurological disease, * Capable of participation: travelling to the institute and filling in the questionnaires.

Exclusion criteria

Exclusion criteria: * Severe pain that is interfering with the pain that the SCS is used for, * Hospitalised or another form of serious decline of general health.

Design outcomes

Primary

MeasureTime frame
Differences in the power in frequency bands in cortical pain processing areas as well as attention areas under the three stimulation settings. Differences in coherence and frequency coupling within pain processing areas, and between pain processing areas and attention areas. Modulation of evoked responses to peripherally applied electrical stimulation.

Secondary

MeasureTime frame
.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)